Division of Infectious Diseases

Treatment of Osteomyelitis – What’s the Evidence for our Strategies?

New UNMC ID publication alert! #ReadUNMCID Recently, the newest member of our Division of Infectious Diseases at UNMC/Nebraska Medicine, Dr. Nicolas Cortes-Penfield published an invited review in Open Forum Infectious Diseases entitled: The History of Antibiotic Treatment of Osteomyelitis.  Dr. Cortes-Penfield wrote this summary describing the review article, which was commissioned after he published a comprehensive blog post (on his blog IDJournalClub.com) about the history… Continue Reading

How Clean is the Hub?

New UNMC ID publication alert! #ReadUNMCID Recently, several members of the Division of Infectious Diseases at UNMC/Nebraska Medicine published a study in American Journal of Infection Control (AJIC) entitled: Microbial colonization of intravascular catheter connectors in hospitalized patients. Drs. Richard Hankins (former ID fellow, class of 2019), and Kelly Cawcutt (Associate Medical Director of Infection Control) are the lead and senior authors on this study. … Continue Reading

When you see CRE: Add Equal Parts Antimicrobial Stewardship and Infection Control

The following was previously posted by Dr. Marcelin to SHEA Journal Club published online in April 2019. Dealing with carbapenem resistant organisms presents both an antimicrobial stewardship and infection control problem. Richter et al. aimed to predict risk factors for carbapenem resistance among Gram-negative rods (CR-GNR). The authors were particularly interested in whether differences exist in risk factors for development of ertapenem-resistance (ER-GNR), versus resistance… Continue Reading

ID Journal Club Presents…Antimicrobial Stewardship in Immunocompromised Patients with Febrile Neutropenia of Unknown Origin– Focusing on Early De-escalation

Targeted therapy and antimicrobial stewardship in patients with febrile neutropenia is difficult because in the vast majority of cases, an organism is not identified, and patients are known to be high risk for serious infections. Antibiotic de-escalation in patients with neutropenic fever varies, with European guidelines recommending 72hr de-escalation and North American guidelines recommending continuation of broad spectrum therapy until neutrophil engraftment. Dr. Jasmine Marcelin… Continue Reading